EntityQ414576· pop 18· linked from 81 articles

triheptanoin

Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).

Key facts

Drug.image: Triheptanoin.svg
Drug.image_class: skin-invert-image
Drug.width: 200
Drug.alt: Skeletal formula of triheptanoin
Drug.image2: Triheptanoin 3D spacefill.png
Drug.image_class2: bg-transparent
Drug.width2: 240
Drug.alt2: Space-filling model of the triheptanoin molecule
Drug.tradename: Dojolvi
Drug.DailyMedID: Triheptanoin
Drug.routes_of_administration: By mouth
Drug.class: Glycerolipids
Drug.ATC_prefix: A16
Drug.ATC_suffix: AX17
Drug.legal_CA: Rx-only
Drug.legal_US: Rx-only
Drug.CAS_number: 620-67-7
Drug.PubChem: 69286

via Wikipedia infobox

Article

7 sections

Contents

Medical uses
History
Names
See also
References
Further reading
External links

Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).

The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea.